<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical outcome of 3 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients with polyclonal hematopoiesis is reported </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were heterozygous for the phosphoglycerate kinase (PGK) gene </plain></SENT>
<SENT sid="2" pm="."><plain>The presence of polyclonal hematopoiesis was determined by the X-chromosome-linked restriction fragment length polymorphism-methylation method using the PGK gene as a marker </plain></SENT>
<SENT sid="3" pm="."><plain>The patients were initially diagnosed as having <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), RA with ring sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), and RA with an excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Their <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> persisted during the follow-up period of 11.4 years for the RA patient, 19.5 years for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> patient and 0.8 years for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> patient </plain></SENT>
<SENT sid="5" pm="."><plain>Although the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> patient continues to be in good health, leukemic transformation occurred in the other 2 patients </plain></SENT>
<SENT sid="6" pm="."><plain>A karyotype change from 46,XX to 45,XX,t(3;21),-7 was observed at the time of disease progression in the RA patient </plain></SENT>
<SENT sid="7" pm="."><plain>The coexistence of a monoclonal <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> clone and <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow cells is thought to be the most probable reason for the polyclonal hematopoiesis of these patients </plain></SENT>
</text></document>